EP2971077 - METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND PREDICTION OF MYOCARDIAL INFARCTION [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 27.03.2020 Database last updated on 09.09.2024 | |
Former | The patent has been granted Status updated on 19.04.2019 | ||
Former | Grant of patent is intended Status updated on 13.12.2018 | ||
Former | Examination is in progress Status updated on 04.11.2016 | Most recent event Tooltip | 08.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 10.08.2022 [2022/32] | Applicant(s) | For all designated states INSERM (Institut National de la Santé et de la Recherche Médicale) 101, rue de Tolbiac 75013 Paris Cédex 13 / FR | For all designated states Université Paris Descartes 12, rue de l'Ecole de Médecine 75006 Paris / FR | For all designated states Sorbonne Université 21 rue de l'Ecole de Médecine 75006 Paris / FR | For all designated states Assistance Publique-Hôpitaux de Paris (APHP) 3, avenue Victoria 75004 Paris / FR | [2019/21] |
Former [2019/02] | For all designated states INSERM (Institut National de la Santé et de la Recherche Médicale) 101, rue de Tolbiac 75013 Paris Cédex 13 / FR | ||
For all designated states Université Paris Descartes 12, rue de l'Ecole de Médecine 75006 Paris / FR | |||
For all designated states Université Pierre et Marie Curie - UPMC 4 Place Jussieu 75005 Paris / FR | |||
For all designated states Assistance Publique-Hôpitaux de Paris (APHP) 3, avenue Victoria 75004 Paris / FR | |||
Former [2016/03] | For all designated states INSERM - Institut National de la Santé et de la Recherche Médicale 101, rue de Tolbiac 75013 Paris / FR | ||
For all designated states Université Paris Descartes 12, rue de l'Ecole de Médecine 75006 Paris / FR | |||
For all designated states Université Pierre et Marie Curie 4, Place Jussieu 75005 Paris / FR | |||
For all designated states Assistance Publique-Hôpitaux de Paris (APHP) 3, avenue Victoria 75004 Paris / FR | Inventor(s) | 01 /
MALLAT, Ziad U970 - INSERM GH Georges Pompidou Broussais 56 Rue Leblanc F-75015 Paris / FR | 02 /
TEDGUI, Alain U970 - INSERM GH Georges Pompidou Broussais 56 Rue Leblanc F-75015 Paris / FR | 03 /
SIMON, Tabassome GU-HUEP Hôpital St Antoine 184 rue du Fbg St Antoine F-75012 Paris / FR | 04 /
DANCHIN, Nicolas U970 - INSERM GH Georges Pompidou Broussais 56 rue Leblanc F-75015 Paris / FR | [2016/03] | Representative(s) | Inserm Transfert PariSanté Campus 10 rue d'Oradour-sur-Glane 75015 Paris / FR | [N/P] |
Former [2019/21] | Inserm Transfert 7, rue Watt 75013 Paris / FR | ||
Former [2016/03] | Hirsch, Denise Marie Inserm Transfert IP Department 7 rue Watt 75013 Paris / FR | Application number, filing date | 14710259.4 | 14.03.2014 | [2016/03] | WO2014EP55059 | Priority number, date | EP20130305299 | 15.03.2013 Original published format: EP 13305299 | [2016/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014140243 | Date: | 18.09.2014 | Language: | EN | [2014/38] | Type: | A1 Application with search report | No.: | EP2971077 | Date: | 20.01.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.09.2014 takes the place of the publication of the European patent application. | [2016/03] | Type: | B1 Patent specification | No.: | EP2971077 | Date: | 22.05.2019 | Language: | EN | [2019/21] | Search report(s) | International search report - published on: | EP | 18.09.2014 | Classification | IPC: | C12Q1/6883, C12Q1/68, C07K16/28 | [2018/48] | CPC: |
C07K16/2875 (EP,US);
C07K16/2878 (US);
C12Q1/6883 (EP,US);
G01N33/6872 (US);
A61K2039/505 (EP,US);
A61K39/3955 (US);
C07K14/525 (US);
C07K2317/76 (EP,US);
C12Q2600/118 (EP,US);
C12Q2600/158 (EP,US);
G01N2333/70575 (US);
G01N2800/324 (US);
|
Former IPC [2016/03] | C12Q1/68, C07K16/28 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/03] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | VERFAHREN UND PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR VERWENDUNG BEI DER BEHANDLUNG UND VORHERSAGE VON MYOKARDINFARKT | [2016/03] | English: | METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND PREDICTION OF MYOCARDIAL INFARCTION | [2016/03] | French: | PROCÉDÉ ET COMPOSITION PHARMACEUTIQUE POUR UNE UTILISATION DANS LE TRAITEMENT ET LA PRÉDICTION D'INFARCTUS DU MYOCARDE | [2018/48] |
Former [2016/03] | PROCÉDÉ ET COMPOSITION PHARMACEUTIQUE DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT ET LA PRÉDICTION D'UN INFARCTUS DU MYOCARDE | Entry into regional phase | 01.09.2015 | National basic fee paid | 01.09.2015 | Designation fee(s) paid | 01.09.2015 | Examination fee paid | Examination procedure | 01.09.2015 | Amendment by applicant (claims and/or description) | 01.09.2015 | Examination requested [2016/03] | 25.10.2016 | Despatch of a communication from the examining division (Time limit: M06) | 11.04.2017 | Reply to a communication from the examining division | 12.06.2017 | Despatch of a communication from the examining division (Time limit: M06) | 22.11.2017 | Reply to a communication from the examining division | 26.03.2018 | Despatch of a communication from the examining division (Time limit: M03) | 22.06.2018 | Reply to a communication from the examining division | 14.12.2018 | Communication of intention to grant the patent | 09.04.2019 | Fee for grant paid | 09.04.2019 | Fee for publishing/printing paid | 09.04.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 25.10.2016 | Opposition(s) | 25.02.2020 | No opposition filed within time limit [2020/18] | Fees paid | Renewal fee | 23.03.2016 | Renewal fee patent year 03 | 23.03.2017 | Renewal fee patent year 04 | 23.03.2018 | Renewal fee patent year 05 | 22.03.2019 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 14.03.2014 | AL | 22.05.2019 | AT | 22.05.2019 | CY | 22.05.2019 | CZ | 22.05.2019 | DK | 22.05.2019 | EE | 22.05.2019 | FI | 22.05.2019 | HR | 22.05.2019 | LT | 22.05.2019 | LV | 22.05.2019 | MC | 22.05.2019 | MK | 22.05.2019 | MT | 22.05.2019 | NL | 22.05.2019 | PL | 22.05.2019 | RO | 22.05.2019 | RS | 22.05.2019 | SE | 22.05.2019 | SI | 22.05.2019 | SK | 22.05.2019 | SM | 22.05.2019 | TR | 22.05.2019 | BG | 22.08.2019 | NO | 22.08.2019 | GR | 23.08.2019 | IS | 22.09.2019 | PT | 22.09.2019 | [2022/31] |
Former [2022/30] | HU | 14.03.2014 | |
AL | 22.05.2019 | ||
AT | 22.05.2019 | ||
CY | 22.05.2019 | ||
CZ | 22.05.2019 | ||
DK | 22.05.2019 | ||
EE | 22.05.2019 | ||
FI | 22.05.2019 | ||
HR | 22.05.2019 | ||
LT | 22.05.2019 | ||
LV | 22.05.2019 | ||
MC | 22.05.2019 | ||
MT | 22.05.2019 | ||
NL | 22.05.2019 | ||
PL | 22.05.2019 | ||
RO | 22.05.2019 | ||
RS | 22.05.2019 | ||
SE | 22.05.2019 | ||
SI | 22.05.2019 | ||
SK | 22.05.2019 | ||
SM | 22.05.2019 | ||
TR | 22.05.2019 | ||
BG | 22.08.2019 | ||
NO | 22.08.2019 | ||
GR | 23.08.2019 | ||
IS | 22.09.2019 | ||
PT | 22.09.2019 | ||
Former [2022/27] | HU | 14.03.2014 | |
AL | 22.05.2019 | ||
AT | 22.05.2019 | ||
CY | 22.05.2019 | ||
CZ | 22.05.2019 | ||
DK | 22.05.2019 | ||
EE | 22.05.2019 | ||
FI | 22.05.2019 | ||
HR | 22.05.2019 | ||
LT | 22.05.2019 | ||
LV | 22.05.2019 | ||
MC | 22.05.2019 | ||
MT | 22.05.2019 | ||
NL | 22.05.2019 | ||
PL | 22.05.2019 | ||
RO | 22.05.2019 | ||
RS | 22.05.2019 | ||
SE | 22.05.2019 | ||
SI | 22.05.2019 | ||
SK | 22.05.2019 | ||
SM | 22.05.2019 | ||
TR | 22.05.2019 | ||
BG | 22.08.2019 | ||
NO | 22.08.2019 | ||
GR | 23.08.2019 | ||
PT | 22.09.2019 | ||
Former [2020/50] | AL | 22.05.2019 | |
AT | 22.05.2019 | ||
CZ | 22.05.2019 | ||
DK | 22.05.2019 | ||
EE | 22.05.2019 | ||
FI | 22.05.2019 | ||
HR | 22.05.2019 | ||
LT | 22.05.2019 | ||
LV | 22.05.2019 | ||
MC | 22.05.2019 | ||
NL | 22.05.2019 | ||
PL | 22.05.2019 | ||
RO | 22.05.2019 | ||
RS | 22.05.2019 | ||
SE | 22.05.2019 | ||
SI | 22.05.2019 | ||
SK | 22.05.2019 | ||
SM | 22.05.2019 | ||
TR | 22.05.2019 | ||
BG | 22.08.2019 | ||
NO | 22.08.2019 | ||
GR | 23.08.2019 | ||
PT | 22.09.2019 | ||
Former [2020/25] | AL | 22.05.2019 | |
AT | 22.05.2019 | ||
CZ | 22.05.2019 | ||
DK | 22.05.2019 | ||
EE | 22.05.2019 | ||
FI | 22.05.2019 | ||
HR | 22.05.2019 | ||
LT | 22.05.2019 | ||
LV | 22.05.2019 | ||
NL | 22.05.2019 | ||
PL | 22.05.2019 | ||
RO | 22.05.2019 | ||
RS | 22.05.2019 | ||
SE | 22.05.2019 | ||
SI | 22.05.2019 | ||
SK | 22.05.2019 | ||
SM | 22.05.2019 | ||
TR | 22.05.2019 | ||
BG | 22.08.2019 | ||
NO | 22.08.2019 | ||
GR | 23.08.2019 | ||
PT | 22.09.2019 | ||
Former [2020/17] | AL | 22.05.2019 | |
AT | 22.05.2019 | ||
CZ | 22.05.2019 | ||
DK | 22.05.2019 | ||
EE | 22.05.2019 | ||
FI | 22.05.2019 | ||
HR | 22.05.2019 | ||
LT | 22.05.2019 | ||
LV | 22.05.2019 | ||
NL | 22.05.2019 | ||
RO | 22.05.2019 | ||
RS | 22.05.2019 | ||
SE | 22.05.2019 | ||
SK | 22.05.2019 | ||
SM | 22.05.2019 | ||
TR | 22.05.2019 | ||
BG | 22.08.2019 | ||
NO | 22.08.2019 | ||
GR | 23.08.2019 | ||
PT | 22.09.2019 | ||
Former [2020/14] | AL | 22.05.2019 | |
AT | 22.05.2019 | ||
CZ | 22.05.2019 | ||
DK | 22.05.2019 | ||
EE | 22.05.2019 | ||
FI | 22.05.2019 | ||
HR | 22.05.2019 | ||
LT | 22.05.2019 | ||
LV | 22.05.2019 | ||
NL | 22.05.2019 | ||
RO | 22.05.2019 | ||
RS | 22.05.2019 | ||
SE | 22.05.2019 | ||
SK | 22.05.2019 | ||
SM | 22.05.2019 | ||
BG | 22.08.2019 | ||
NO | 22.08.2019 | ||
GR | 23.08.2019 | ||
PT | 22.09.2019 | ||
Former [2020/11] | AL | 22.05.2019 | |
AT | 22.05.2019 | ||
CZ | 22.05.2019 | ||
DK | 22.05.2019 | ||
EE | 22.05.2019 | ||
FI | 22.05.2019 | ||
HR | 22.05.2019 | ||
LT | 22.05.2019 | ||
LV | 22.05.2019 | ||
NL | 22.05.2019 | ||
RO | 22.05.2019 | ||
RS | 22.05.2019 | ||
SE | 22.05.2019 | ||
SK | 22.05.2019 | ||
BG | 22.08.2019 | ||
NO | 22.08.2019 | ||
GR | 23.08.2019 | ||
PT | 22.09.2019 | ||
Former [2020/10] | AL | 22.05.2019 | |
AT | 22.05.2019 | ||
CZ | 22.05.2019 | ||
DK | 22.05.2019 | ||
FI | 22.05.2019 | ||
HR | 22.05.2019 | ||
LT | 22.05.2019 | ||
LV | 22.05.2019 | ||
NL | 22.05.2019 | ||
RO | 22.05.2019 | ||
RS | 22.05.2019 | ||
SE | 22.05.2019 | ||
BG | 22.08.2019 | ||
NO | 22.08.2019 | ||
GR | 23.08.2019 | ||
PT | 22.09.2019 | ||
Former [2020/09] | AL | 22.05.2019 | |
CZ | 22.05.2019 | ||
DK | 22.05.2019 | ||
FI | 22.05.2019 | ||
HR | 22.05.2019 | ||
LT | 22.05.2019 | ||
LV | 22.05.2019 | ||
NL | 22.05.2019 | ||
RS | 22.05.2019 | ||
SE | 22.05.2019 | ||
BG | 22.08.2019 | ||
NO | 22.08.2019 | ||
GR | 23.08.2019 | ||
PT | 22.09.2019 | ||
Former [2019/51] | AL | 22.05.2019 | |
FI | 22.05.2019 | ||
HR | 22.05.2019 | ||
LT | 22.05.2019 | ||
LV | 22.05.2019 | ||
NL | 22.05.2019 | ||
RS | 22.05.2019 | ||
SE | 22.05.2019 | ||
BG | 22.08.2019 | ||
NO | 22.08.2019 | ||
GR | 23.08.2019 | ||
PT | 22.09.2019 | ||
Former [2019/50] | AL | 22.05.2019 | |
FI | 22.05.2019 | ||
HR | 22.05.2019 | ||
LT | 22.05.2019 | ||
LV | 22.05.2019 | ||
NL | 22.05.2019 | ||
RS | 22.05.2019 | ||
SE | 22.05.2019 | ||
NO | 22.08.2019 | ||
GR | 23.08.2019 | ||
PT | 22.09.2019 | ||
Former [2019/49] | AL | 22.05.2019 | |
FI | 22.05.2019 | ||
HR | 22.05.2019 | ||
LT | 22.05.2019 | ||
NL | 22.05.2019 | ||
SE | 22.05.2019 | ||
NO | 22.08.2019 | ||
PT | 22.09.2019 | ||
Former [2019/48] | FI | 22.05.2019 | |
LT | 22.05.2019 | ||
SE | 22.05.2019 | ||
NO | 22.08.2019 | ||
PT | 22.09.2019 | ||
Former [2019/47] | FI | 22.05.2019 | |
LT | 22.05.2019 | ||
NO | 22.08.2019 | Cited in | International search | [X]WO0216411 (HUMAN GENOME SCIENCES INC [US]) [X] 4-8* page 95, line 22 - page 96, line 26 *; | [X]US2003223996 (RUBEN STEVEN M [US], et al) [X] 4-8 * paragraph [0459] - paragraph [0460]; claims 1,76-79 *; | [X]US2005048626 (DESJARLAIS JOHN R [US], et al) [X] 4-8 * paragraph [0225] *; | [X]WO2005042009 (BIOGEN IDEC INC [US], et al) [X] 4-8 * example 3; claim 9 * * paragraph [0015] *; | [XI] - PHILIP KAHN ET AL, "Prevention of murine antiphospholipid syndrome by BAFF blockade", ARTHRITIS & RHEUMATISM, (20080901), vol. 58, no. 9, doi:10.1002/art.23764, ISSN 0004-3591, pages 2824 - 2834, XP055067459 [X] 4-8 * page 2824; figures 1,3 * [I] 1-3,9 DOI: http://dx.doi.org/10.1002/art.23764 | by applicant | US4816397 | US4946778 | US5225539 | WO9932619 | WO0043032 | WO0124811 | WO0136646 | WO0160397 | WO0168836 | WO02066516 | US6506559 | US6573099 | WO2004011611 | WO2004081043 | WO2006025345 | WO2006034106 | US7109304 | CN101851291 | - HOHEISEL, NATURE REVIEWS, GENETICS, (2006), vol. 7, pages 200 - 210 | - THOMAS D6MER; PETER E, "Lipsky, B-cell targeting: a novel approach to immune intervention today and tomorrow", EXPERT OPINION ON BIOLOGICAL THERAPY, (200709), vol. 7, no. 9, pages 1287 - 1299, XP009133112 | - LEONARD ET AL., CLINICAL CANCER RESEARCH, (2004), vol. 10, pages 53Z7 - 5334 | - DE BENEDETTI ET AL., J IMMUNOL, (2001), vol. 166, pages 4334 - 4340 | - SUZUKI ET AL., EUROP J OF IMMUNOL, (1992), vol. 22, no. 8, pages 1989 - 1993 | - AIT-OUFELLA, H. ET AL., "B cell depletion reduces the development of atherosclerosis in mice", J EXP MED, (2010), vol. 207, pages 1579 - 1587 | - ARMSTRONG, P.W. ET AL., "Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial", JAMA, (2007), vol. 297, pages 43 - 51 | - BUSCHE, M.N.; PAVLOV, V.; TAKAHASHI, K.; STAHL, G.L., "Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin", AM J PHYSIOL HEART CIRC PHYSIOL, (2009), vol. 297, pages H1853 - 1859 | - CAZES, A. ET AL., "Mechanical ventricular assistance in heart failure: pathology of the cardiac apex removed during device implantation", CARDIOVASC PATHOL, (2010), vol. 19, pages 112 - 116, XP026878669 | - COCHAIN, C. ET AL., "Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization", CARDIOVASC RES, (2010), vol. 88, pages 186 - 195 | - EIKELBOOM, J.W.; O'DONNELL, M., "Pexelizumab does not ''complement'' percutaneous coronary intervention in patients with ST-elevation myocardial infarction", JAMA, (2007), vol. 297, pages 91 - 92 | - GRANGER, D.N.; KORTHUIS, R.J., "Physiologic mechanisms ofpostischemic tissue injury", ANNU REV PHYSIOL, (1995), vol. 57, pages 311 - 332 | - GRANGER, C.B. ET AL., "Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial", CIRCULATION, (2003), vol. 108, pages 1184 - 1190 | - GULLICK NICOLA; D'CRUZ DAVID, "New therapies for the treatment of systemic lupus erythematosus", EXPERT OPIN. THER. PATENTS, (2007), vol. 17, no. 3 | - HAAS, M.S. ET AL., "Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction", CARDIOVASC RES, (2010), vol. 87, doi:doi:10.1093/CVR/CVQ141, pages 618 - 627, XP002698347 DOI: http://dx.doi.org/10.1093/CVR/CVQ141 | - LEUSCHNER, F. ET AL., "Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis", J EXP MED, (2012), vol. 209, pages 123 - 137 | - MAHAFFEY, K.W. ET AL., "Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial", CIRCULATION, (2003), vol. 108, pages 1176 - 1183 | - NAHRENDORF, M. ET AL., "The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions", J EXP MED, (2007), vol. 204, pages 3037 - 3047 | - SHAH, A.M.; MANN, D.L., "In search of new therapeutic targets and strategies for heart failure: recent advances in basic science", LANCET, (2011), vol. 378, pages 704 - 712 | - UCHIDA, J. ET AL., "Mouse CD20 expression and function", INT IMMUNOL, (2004), vol. 16, doi:doi:10.1093/intimm/dxh009, pages 119 - 129, XP003013383 DOI: http://dx.doi.org/10.1093/intimm/dxh009 | - VINTEN-JOHANSEN, J., "Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury", CARDIOVASC RES, (2004), vol. 61, pages 481 - 497 | - WHITE, H.D.; CHEW, D.P., "Acute myocardial infarction", LANCET, (2008), vol. 372, pages 570 - 584 |